← Eichor
Study identifier: NCT05753683 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Gathering Online for Dialogue and Discussion to Enhance Social Support

Condition: Alcohol Misuse · HIV · Sexually Transmitted Infections  ·  Sponsor: RTI International

PhaseNA
Planned participants500
Who can joinAll sexes, 18 Years to 30 Years
Healthy volunteersYes

About this study

The goal of this trial is to test a modified mobile health intervention (with a group component) relative to a mobile health intervention in a two-arm randomized trial with up to 500 young women who are human immunodeficiency virus (HIV)-negative and who misuse alcohol. The expected outcomes are to: (1) determine the efficacy of the virtual group component in reducing alcohol use and sexual risk and increasing pre-exposure prophylaxis (PrEP) utilization; and (2) understand selected outcomes for implementation. Participants will be randomized to receive either the mHealth app or the mHealth app plus the group component, and followed up at 3- and 6-months post-enrollment.

This description comes directly from the study's public registry record.

Talk to the study team

Felicia A Browne, ScD, MPH  ·  9195416596  ·  fbrowne@rti.org

Always discuss trial participation with your own doctor first.

Locations (1)

RTI InternationalDurham, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05753683